Pharma Stability: Insights, Guidelines, and Expertise
SOP for Conducting Stability Studies in Compliance with Japanese Regulatory Requirements (PMDA) Guidelines for Stability Studies as per Japanese PMDA Requirements 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability studies for drug substances and drug products in accordance with the Pharmaceutical and Medical Device Agency (PMDA)…
SOP for Managing Stability Testing of Post-Approval Changes According to US FDA Guidelines Guidelines for Stability Testing of Post-Approval Changes 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for conducting stability testing for post-approval changes to drug substances and products in accordance with US FDA guidelines. This SOP…
SOP for Applying ICH Q1C Guidelines for Stability Testing of New Dosage Forms Guidelines for Stability Testing of New Dosage Forms as per ICH Q1C 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedure for conducting stability testing of new dosage forms in accordance with the ICH Q1C guidelines….
Read More “SOP for Applying ICH Q1C Guidelines for Stability Testing of New Dosage Forms” »
SOP for Developing Stability Study Reports for ANDA Submissions Guidelines for Stability Study Reports for ANDA Submissions 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for preparing stability study reports for Abbreviated New Drug Application (ANDA) submissions to the United States Food and Drug Administration (US FDA). This SOP…
Read More “SOP for Developing Stability Study Reports for ANDA Submissions” »
SOP for Documenting Stability Studies for New Drug Applications (NDAs) to the US FDA Guidelines for Documentation of Stability Studies for NDAs 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for documenting stability studies for New Drug Applications (NDAs) to the United States Food and Drug Administration (US FDA)….
Read More “SOP for Documenting Stability Studies for New Drug Applications (NDAs) to the US FDA” »
SOP for Developing a Stability-Indicating Method in Compliance with ICH Q2(R1) Guidelines for Creating Stability-Indicating Methods as per ICH Q2(R1) 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for developing and validating a stability-indicating method for drug substances and drug products in accordance with the ICH Q2(R1) guidelines….
Read More “SOP for Developing a Stability-Indicating Method in Compliance with ICH Q2(R1)” »
SOP for Managing Stability Testing of Post-Approval Changes According to US FDA Guidelines Guidelines for Stability Testing of Post-Approval Changes 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for conducting stability testing for post-approval changes to drug substances and products in accordance with US FDA guidelines. This SOP…
SOP for Applying ICH Q1C Guidelines for Stability Testing of New Dosage Forms Guidelines for Stability Testing of New Dosage Forms as per ICH Q1C 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedure for conducting stability testing of new dosage forms in accordance with the ICH Q1C guidelines….
Read More “SOP for Applying ICH Q1C Guidelines for Stability Testing of New Dosage Forms” »
SOP for Developing Stability Study Reports for ANDA Submissions Guidelines for Stability Study Reports for ANDA Submissions 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for preparing stability study reports for Abbreviated New Drug Application (ANDA) submissions to the United States Food and Drug Administration (US FDA). This SOP…
Read More “SOP for Developing Stability Study Reports for ANDA Submissions” »
SOP for Documenting Stability Studies for New Drug Applications (NDAs) to the US FDA Guidelines for Documentation of Stability Studies for NDAs 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for documenting stability studies for New Drug Applications (NDAs) to the United States Food and Drug Administration (US FDA)….
Read More “SOP for Documenting Stability Studies for New Drug Applications (NDAs) to the US FDA” »